Navigation Links
Karolinska Institutet Awards Honorary Degree to Feinstein Institute CEO Kevin J. Tracey, MD
Date:5/15/2009

STOCKHOLM, Sweden, May 15 /PRNewswire-USNewswire/ -- The Karolinska Institutet in Stockholm today awarded an honorary post-doctoral degree to Kevin J. Tracey, MD, director and chief executive officer of The Feinstein Institute for Medical Research in Manhasset, NY.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090515/DC17878)

Dr. Tracey, a neurosurgeon whose work has helped unravel how the brain communicates with the immune system, joins a long and distinguished list of scientists who have received this honor from the Karolinska Institutet, including Nobel Prize winners Paul Greengard, PhD, and Torsten Weisel, PhD, both at Rockefeller University in Manhattan.

Each year, the Karolinska Institutet awards three honorary degrees to scientists selected by the Karolinska's Board of Research. Others honored today by the Karolinska at Stockholm City Hall were Hakan Mogren, one of Sweden's most prominent figures within trade and industry, and Ulla Fohrer, a speech therapist and researcher at Karolinska Institutet. The three honorees received their doctoral hats, diplomas and rings from the Dean of Research as confirmation of their new status.

Dr. Tracey's discoveries have paved the way for the development of new medicines to treat chronic rheumatoid arthritis, inflammatory bowel disease and infection. He has made considerable contributions towards improving knowledge of regulating inflammatory processes.

The Karolinska Institutet is one of the leading medical universities in Europe. Through research and education, the Karolinska Institutet contributes to improving human health. Each year, the Nobel Assembly at the Karolinska Institutet awards the Nobel Prize in Physiology or Medicine.

In 2008, the Karolinska Institutet and the Feinstein Institute signed a collaborative agreement that paves the way for Karolinska graduates to conduct post-doctoral research in New York and scientists from the Feinstein to study at the Karolinska's laboratories in Stockholm.

About The Feinstein Institute for Medical Research: Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in cancer, leukemia, lymphoma, Parkinson's disease, Alzheimer's disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, inflammatory bowel disease, diabetes, human genetics, neuroimmunology, and medicinal chemistry. Feinstein researchers are developing new drugs and drug targets, and producing results where science meets the patient, annually enrolling some 10,000 subjects into clinical research programs.


'/>"/>
SOURCE The Feinstein Institute for Medical Research
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Karolinska Development Invests in EvoStem Finland Oy
2. Dr. Henry Barnett becomes first person outside Europe to receive Karolinska Stroke Award
3. The Feinstein to collaborate with Swedens Karolinska Institute
4. 3 new honorary doctors at Karolinska Institutet
5. Karolinska Institutets Pedersen to receive GSAs 2007 Distinguished Career Award
6. YWCA USA 2009 Hallmark Initiative Awards Presented to YWCA Central Massachusetts and YWCA Niagara
7. Eleventh Annual Welcome Back Awards Program Honors Individuals who Positively Impact the Depression Community
8. SGNA Honors Outstanding Gastroenterology and Endoscopy Professionals With Nationwide Awards
9. ScienceFirst Receives ADCNJ Awards
10. ADA Foundation Hosts Second Give Kids A Smile Awards Gala
11. HealthWorldNet.com Announces HealthWiNs Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... , ... "I have gout, and I wanted to treat it naturally," said ... to relieve gout and pain caused by varicose veins. I drank it every morning ... relieved what VA doctors called the worst sinusitis case they'd seen and relieved gas, ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name Medical Center ... NY, on December 3rd, to benefit Holy Name Medical Center's programs and services. ... raised over $1 million - the largest event in the Center's history, both ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric ... patient safety. Only a few hospitals and facilities have earned this distinction. This ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced the ... and Eric Hoessel to vice president of sales. , Litsinger joined Mirixa ...
(Date:12/8/2016)... ... 08, 2016 , ... SunView Software aims to redefine IT ... both engaging and easy to use. Coming off the heels of a successful ... its plans to roll out new AI-powered self-service enhancements to help organizations implement ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... 9, 2016 Research and Markets has ... report to their offering. ... The report forecasts the global optical transceiver market ... The report covers the present scenario and the ... calculate the market size, the report considers the revenue generated from ...
(Date:12/9/2016)... aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company ... severe, rare diseases, today announced that senior management will participate in ... Conference at the InterContinental Barclay Hotel in New York ... ET. About aTyr Pharma ... aTyr Pharma is engaged in the ...
(Date:12/9/2016)... Bermuda , Dec. 9, 2016  Axovant ... leading clinical-stage biopharmaceutical company focused on the treatment ... the data from a Phase 2b trial evaluating ... care donepezil, compared with donepezil plus placebo in ... that the addition of intepirdine to treatment was ...
Breaking Medicine Technology: